Endocrinology RACP MCQs Flashcards
RACP 2022a
8. 69 year old man presenting with intermittent headaches and fatigue. Low testosterone and high prolactin. Lots of blood results. Prolactin 77000,
GH/LH/FSH/cortisol normal. MRI with lesion size (20mmx16mmx-18mm) that is in close proximity to optic chiasm. His formal visual field testing is normal.
What is the best management?
a. Somatostatin analogue
b. Dopamine agonist
c. Transsphenoidal surgery
ANS: C
https://www.ncbi.nlm.nih.gov/books/NBK278983/
RACP 2022a
14. An 18 year old male presents with bilateral painful gynecomastia. Resting tachycardia on exam. He has high total testosterone, normal free testosterone (4.5) and elevated SHBG (192). FSH and LH (low normal, not suppressed), prolactin normal, TSH < 0.01. His BMI is 18. What is the most likely cause
a. Exogenous testosterone use
b. Pituitary adenoma
c. Grave’s Disease
ANS: C
SHBG increased with hypogonadism, anorexia, T1DM, hyperthyroidisim, aromatase inhibitors
Gynaecomastia can be caused by hyperthyroidism
RACP 2022a
19. A 24 year old man has a testicular rest tumour on a background of congenital adrenal insufficiency. What is the management of the adrenal rest tumour?
a. Bilateral Orchidectomy
b. Cisplatin-based chemotherapy
c. Lepirudin (GnRH analogue)
d. Steroids
ANS: D
First line treatment = steriods
Then surgery if persistent
RACP 2022a 21.A patient with type 1 diabetes is calculating his next short-acting insulin dose.
He normally takes insulin glargine 18 units before bed. His pre-breakfast BSL is 12.9 and his target is 6. His normal carbohydrate loading is 1 units rapid-acting insulin for every 10g of carbohydrate. His insulin sensitivity factor is 3.
He anticipates his breakfast has 60g of carbohydrates. What should his pre-
meal insulin be?
a. 6
b. 8
c. 4
ANS: B
2 units + 6 U with breakfast = 8
RACP 2022a 63.In which format does hormone replacement therapy have the least side
effects?
a. Mini progesterone pill + transdermal oestrogen patch
b. Other options inc non micronised, and oral oestrogens
ANS: A
RACP 2022a
66.70yo male with Bony met prostate Ca
Ca 2.78 (2.20-2.55)
PTH 7.5 (1.7-7.3)
Urine Ca to Cr 0.41 <0.61
What is the most likely cause of hypercalcemia?
a. Bony erosions
b. Hyperparathyroidism
c. Exogenous Vit D production
d. PTHrP
ANS: B
Demonstrates PTH dependent hypercalcaemia
A, C and D are causes of PTH independent hypercalcaemia
RACP 2022b 4. What cell type produces testosterone in the testes?
A. Granulosa
B. Leydig
C. Sertoli
D. Theca
ANS: B
Leydig for testosterone
Sertoli for spermatogenesis
Theca cells are a group of endocrine cells in the ovary made up of connective tissue surrounding the follicle. They have many diverse functions, including promoting folliculogenesis and recruitment of a single follicle during ovulation.
RACP 2022b 20. What are the primary metabolites of testosterone?
A) andostenedione and estrone
B) dihydrotestosterone and oestradiol
C) progesterone and DHEA
D) pregnenolone and something
ANS: B
Testosterone undergoes pre-receptor activation by conversion to potent bioactive metabolites, DHT and estradiol. The steroidogenic enzyme 5α-reductase has two isozymes, types 1 and 2, which form a local androgen amplification mechanism converting testosterone to the most potent natural androgen, DHT
RACP 2022b 22. Which drugs stop the release of pre-made thyroid hormone?
A. Prednisone and dexamethasone
B. Lithium and iodine
C. Carbimazole and PTU
ANS: B
Treatment include administration of thionamide therapy with methimazole or PTU to stop the synthesis of new thyroid hormone and Iodine to stop the release of pre-formed hormone.
RACP 2022b 31. Why is HBa1c lower in pregnant women?
A. Iron deficiency
B. Increased cell turnover
C. Presence of foetal haemoglobin
ANS: B
HbA1c reduced due to longer average cell life in pregnancy
RACP 2021a Q33. What are the two other Rotterdam criteria for PCOS, in addition to an ultrasound finding of polycystic
ovaries?
A. Increased LH:FSH ratio and clinical evidence of hyperandrogenism
B. Increased LH:FSH ratio and primary infertility
C. Oligo/anovulation and clinical evidence of hyperandrogenism
D. Oligo/anovulation and insulin resistance
ANS: C
RACP 2021a Q76. What complication can you avoid in a patient being given topical oestrogen as opposed to oral oestrogen, in a patient with functional hypothalamic amenorrhea requiring oestrogen replacement?
A. Low BMD
B. Infertility
C. Genital atrophy
D. Endometrial hypertrophy
ANS: D
Transdermal estrogen has been shown to avoid this risk because it delivers a more physiologic release of hormones without the first-pass hepatic metabolism seen with oral estrogen, which increases estrogen levels and risks of endometrial stimulation. Furthermore, when estrogen is delivered transdermally, the metabolic and coagulation impacts are minimized compared to oral estrogen therapy.
A study that supports the use of transdermal estrogen over oral forms to avoid these complications is the ESTHER study, which demonstrated that transdermal estrogen avoids some of the adverse effects associated with oral estrogen, such as venous thromboembolism and other metabolic complications .
RACP 2021a Q87. What is the most appropriate test to diagnose suspected secondary adrenal insufficiency in an elderly patient?
A. Morning ACTH and cortisol
B. Serum cortisol measured 30 minutes after synthetic ACTH administration (short synacthen test)
C. Serum cortisol measured 30 minutes following insulin-induced hypoglycaemia (insulin tolerance test)
D. Serum cortisol measured 72 hours after synthetic ACTH administration (long synacthen test)
ANS: B
RACP 2021 Q93/Q94 EMQ – Match the following genetic cancer syndromes from the list of options:
A. MEN1
B. RET
C. VHL
D. SDHA
E. SDHB
F. HPNCC
G. MLH1
H. PTEN
I. PKP2R*
J. NF1*
*Not sure if these two were options.
Q93. Patient presents with pancreatic cancer, pituitary adenoma and hyperparathyroidism
ANS: A
A - Multiple Endocrine Neoplasia 1
B - Multiple Endocrine Neoplasia 2
C - Von Hippel Lindau
D - phaeochromocytoma
E - phaeochromocytoma, paraganglioma
F - Lynch
G - TSG for Adenocarcinoma
H - Endometrial, glial and prostate Ca
I - Arrhythmogenic right ventricular cardiomyopathy (ARVC)
J - Neurofibromatosis
RACP 2021a Q93/Q94 EMQ – Match the following genetic cancer syndromes from the list of options:
A. MEN1
B. RET
C. VHL
D. SDHA
E. SDHB
F. HPNCC
G. MLH1
H. PTEN
I. PKP2R*
J. NF1*
*Not sure if these two were options.
Q94. Patient presents with retinal angioblastoma, cerebellar hemangioma and a large renal mass.
ANS: C
RACP 2021b Q111. In a patient with nephrogenic diabetes insipidus due to lithium, adjunctive treatment with amiloride will help by blocking transport of which ion?
A. Calcium
B. Chloride
C. Potassium
D. Sodium
ANS: D
- Lithium is cleared in the kidneys
- Amiloride is indicated in patients with lithium-induced NDI and continue lithium: blocks lithium entry by blocking the epithelial sodium channels through which lithium gets reabsorbed
RACP 2021b Q115. What is the site of action of sulfonylurea drugs on pancreatic beta cells?
A. AMP kinase enzyme
B. ATP sensitive potassium channels
C. Glucokinase enzyme
D. Insulin storage vesicles
ANS: B
These drugs exert their hypoglycaemic effects by stimulating insulin secretion from the pancreatic beta-cell. Their primary mechanism of action is to close ATP-sensitive K-channels in the beta-cell plasma membrane, and so initiate a chain of events which results in insulin release.
RACP 2021b Q138. High titres of antibodies to what target correlate with the presence and severity of extra-thyroidal
manifestations of Graves’ disease?
A. Thyroglobulin
B. Thyroid microsomal
C. Thyroperoxidase
D. Thyrotrophin (TSH) receptor
ANS: D
RACP 2021b Q143. Where is the principle site of the production of mineralocorticoids?
A. Adrenal medulla
B. Zona glomerulosa
C. Zona fasciculata
D. Zona reticularis
ANS: B
RACP 2021b Q160. Which hormone released from anterior pituitary is regulated by tonic inhibition?
A. ACTH
B. GH
C. Prolactin
D. TSH
Answer B Prolactin is regulated by tonic inhibition by dopamine
RACP 2021o 13. Hyperthyroidism in pregnancy (11-12 weeks pregnant). T4 at ULN and T3
slightly elevated with suppressed TSH 0.01. Other than hyperemesis gravidarum,
she has been asymptomatic and uncomplicated pregnancy so far. Tachycardic to
102 bpm, normotensive. Next step in management ?
A. PTU
B. No treatment currently
C. Propranolol and PTU
D. Propranolol
B. No treatment currently.
Rationale:
Subclinical hyperthyroidism is often transient in pregnancy due to the influence of hCG, which can suppress TSH. This is common in early pregnancy and does not always require treatment unless the patient is symptomatic or has significant biochemical hyperthyroidism (very high levels of T3/T4).
The patient is largely asymptomatic aside from mild tachycardia, which can be a normal physiological response to pregnancy or mild hyperthyroidism.
PTU (propylthiouracil) or methimazole is indicated in pregnant women with overt hyperthyroidism to prevent complications. However, in this case, treatment might not be necessary as her thyroid hormone levels are near normal.
Propranolol (D) is used for symptom control in hyperthyroid patients with significant symptoms like severe tachycardia or palpitations, but it is not necessary in asymptomatic or mildly symptomatic patients like this one.
According to the Australian Thyroid Association and Endocrine Society Guidelines, monitoring is recommended for subclinical or mild hyperthyroidism during pregnancy, especially in the first trimester when the physiological rise in hCG can suppress TSH. If symptoms worsen or hormone levels rise significantly, then treatment can be reconsidered.
RACP 2021o 14. Hyperthyroidism during pregnancy - which thyroid marker/antibody crosses
placenta and can induce foetal hyperthyroidism
a. T3
b. T4
c. Thyrotropin releasing hormone
d. Thyroid stimulating hormone
RACP 2021o 43. Nurse has stereotyped hypoglycemic symptoms. It always comes after fasting and improves with carbohydrate meals.
BSL 2.4, Cortisone 1500, Low c peptide, insulin just above normal level. What is the most likely diagnosis?
a. Insulinoma
b. Exogenous insulin
c. Cushing’s
Answer C
RACP 2020 18.
A 24 yo female in her 1st trimester presents with palpitations and ?heat intolerance (symptoms
of hyperthyroidism). She has chemosis and a goitre. Her lab details are: T4 21 (upper limit of
normal), TSH <0.001 (below normal limits), T3 5.1 (normal limits), bHCG 3000+ (way above
normal limits). What therapy do you recommend?
A) Carbimazole
B) PTU
C) Prednisolone
D) Observation